SARS-CoV-2; from vaccine development to drug discovery and prevention guidelines Page 1
AIMS Molecular Science, 7(3): 281–291. DOI: 10.3934/molsci.2020013 Received: 15 June …

New SARS-CoV-2 mutants have been continuously indentified with enhanced transmission
ever since its outbreak in early 2020. As an RNA virus, SARS-CoV-2 has a high mutation …

SARS-CoV-2 genome annotation revealed the presence of 10 open reading frames (ORFs),
of which the last one (ORF10) is positioned downstream of the N gene. It is a hypothetical …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the
end of 2019 stimulated vigorous research efforts in immunology and vaccinology. In addition …

The shell disorder models have predicted that SARS-CoV-2 is of a specific but peculiar
evolutionary nature. All coronaviruses (CoVs) closely related to SARS-CoV-2 have been …

The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from
China has become a global threat due to the continuous rise in cases of Coronavirus …

Human coronaviruses have become an increasing threat to global health; three highly
pathogenic strains have emerged since the early 2000s, including most recently SARS-CoV …

In late December 2019, a vtiral pneumonia with an unknown agent was reported in Wuhan,
China. A novel coronavirus was identified as the causative agent. Because of the human-to …

The COVID-19 pandemic has highlighted the importance in the understanding of the biology
of SARS-CoV-2. After more than two years since the first report of COVID-19, it remains …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(2019-nCoV), is a positive-
sense, single-stranded RNA coronavirus. The virus is the causative agent of coronavirus …